Profile
Carlos R.
Camozzi worked as a Chief Medical Officer and Principal at various pharmaceutical companies including Orphan Europe SARL, Mepha AG, Roche Corp., and Orphazyme A.
He also served as the Chief Medical Officer and Vice President at uniQure NV.
Prior to that, he was the Chief Medical Officer at Amsterdam Molecular Therapeutics (AMT) Holding NV.
He worked as a Scientific Strategy Director at Universitätsspital Basel and was a Member-Molecular Pathology at the University of Basel.
He also worked as a Principal at Wyeth Holdings LLC and F.
Hoffmann-La Roche Ltd.
In terms of education, he earned a doctorate degree from Universidad de Buenos Aires.
Former positions of Carlos R. Camozzi
Companies | Position | End |
---|---|---|
NLS PHARMACEUTICS LTD. | Chief Tech/Sci/R&D Officer | 2022-08-31 |
Syndermix AG
Syndermix AG Household/Personal CareConsumer Non-Durables Syndermix AG manufactures skin and beauty care products. The private company is based in Nidwalden, Switzerland and has subsidiaries in Switzerland. | Chief Tech/Sci/R&D Officer | 2020-09-30 |
Simbec-Orion Group Ltd.
Simbec-Orion Group Ltd. Pharmaceuticals: MajorHealth Technology Simbec-Orion Group Ltd. provides contract research services for rare and orphan conditions. The firm offers services for oncology, orphan diseases, respiratory, dermatology, infectious vaccines and diseases. The company was founded in 2014 and is headquartered in Pentrebach, the United Kingdom. | Chief Tech/Sci/R&D Officer | 2017-09-30 |
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Chief Tech/Sci/R&D Officer | 2013-03-10 |
Universitätsspital Basel
Universitätsspital Basel Hospital/Nursing ManagementHealth Services Universitätsspital Basel provides medical services. It offers medical facilities for the welfare, safety and recovery of patients. The company is headquartered in Basel, Switzerland. | Chief Tech/Sci/R&D Officer | - |
Training of Carlos R. Camozzi
Universidad de Buenos Aires | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
ORPHAZYME A/S | Health Technology |
UNIQURE N.V. | Health Technology |
NLS PHARMACEUTICS LTD. | Health Technology |
Private companies | 9 |
---|---|
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Process Industries |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Commercial Services |
Mepha AG
Mepha AG Pharmaceuticals: MajorHealth Technology Mepha develops and makes interesting pharmaceuticals in Switzerland, as well as offering attractive services, so that doctors and pharmacists can treat their patients both more effectively and in a more price-conscious way. This is achieved by team work and innovative spirit, examples of which are as follows. Its innovative dosage forms are more readily accepted by patients, so the patient compliance is higher, which makes for a more effective treatment. It has been involved in the fight against malaria for over 20 years, and introduced a state-of-the-art combination drug with the active substances mefloquine and artesunate (Artequin™) on the international market in 2002 for the treatment of this disease. It can offer many creative services and target-oriented two-way communication to help its clients in the treatment of their patients. Its highly motivated employees add their friendly approach to its comprehensive portfolio for the benefit of its clients. | Health Technology |
Roche Corp. | |
Universitätsspital Basel
Universitätsspital Basel Hospital/Nursing ManagementHealth Services Universitätsspital Basel provides medical services. It offers medical facilities for the welfare, safety and recovery of patients. The company is headquartered in Basel, Switzerland. | Health Services |
Simbec-Orion Group Ltd.
Simbec-Orion Group Ltd. Pharmaceuticals: MajorHealth Technology Simbec-Orion Group Ltd. provides contract research services for rare and orphan conditions. The firm offers services for oncology, orphan diseases, respiratory, dermatology, infectious vaccines and diseases. The company was founded in 2014 and is headquartered in Pentrebach, the United Kingdom. | Health Technology |
Syndermix AG
Syndermix AG Household/Personal CareConsumer Non-Durables Syndermix AG manufactures skin and beauty care products. The private company is based in Nidwalden, Switzerland and has subsidiaries in Switzerland. | Consumer Non-Durables |
Orphan Europe SARL
Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Orphan Europe SARL develops and distributes orphan drugs for the treatment of rare diseases. The firm's products include Normosang, Cystagon, Pedea, Carbaglu, Wilzin, Cystadane. The company was founded by William Gunnarsson in 1990 and is headquartered in Puteaux, France. | Health Technology |
- Stock Market
- Insiders
- Carlos R. Camozzi